Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Intraoperative Ultrasound Staging for Colorectal Liver Metastases in the Era of Liver-Specific Magnetic Resonance Imaging: Is It Still Worthwhile?

Langella S, Ardito F, Russolillo N, Panettieri E, Perotti S, Mele C, Giuliante F, Ferrero A.

J Oncol. 2019 Sep 22;2019:1369274. doi: 10.1155/2019/1369274. eCollection 2019.

2.

Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging.

De Gaetano AM, Catalano M, Pompili M, Marini MG, Rodríguez Carnero P, Gullì C, Infante A, Iezzi R, Ponziani FR, Cerrito L, Marrone G, Giuliante F, Ardito F, Rapaccini GL, Vecchio FM, Giraldi L, Manfredi R; HEPATOCATT STUDY GROUP.

Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7786-7801. doi: 10.26355/eurrev_201909_18988.

3.

Surgical Management of Hepatic Benign Disease: Have the Number of Liver Resections Increased in the Era of Minimally Invasive Approach? Analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry.

Ardito F, Aldrighetti L, Guglielmi A, Jovine E, Cillo U, Ferrero A, De Carlis L, Belli G, Dalla Valle R, Slim A, Mazzaferro V, Navarra G, Ettorre GM, Calise F, Pinna AD, Giuliante F; Italian Group of Minimally Invasive Liver Surgery (I Go MILS).

J Gastrointest Surg. 2019 Sep 10. doi: 10.1007/s11605-019-04260-7. [Epub ahead of print]

PMID:
31506894
4.

Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases.

Gallotta V, Conte C, D'Indinosante M, Capoluongo E, Minucci A, De Rose AM, Ardito F, Giuliante F, Di Giorgio A, Zannoni GF, Fagotti A, Margreiter C, Scambia G, Ferrandina G.

Eur J Surg Oncol. 2019 Nov;45(11):2096-2102. doi: 10.1016/j.ejso.2019.06.023. Epub 2019 Jun 13.

PMID:
31227342
5.

Circulating tumor cell-related transcripts in blood as prognostic biomarkers of early recurrence after liver resection for colorectal metastases.

Giuliante F, Panettieri E, Ardito F, De Rose A, Pocino K, Autilio C, Paolillo C, Capoluongo ED.

Int J Biol Markers. 2019 Sep;34(3):269-275. doi: 10.1177/1724600819849438. Epub 2019 Jun 18.

PMID:
31213130
6.

The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas.

Ardito F, Panettieri E, Vellone M, Ferrucci M, Coppola A, Silvestrini N, Arena V, Adducci E, Capelli G, Vecchio FM, Giovannini I, Nuzzo G, Giuliante F.

Surgery. 2019 Apr;165(4):712-720. doi: 10.1016/j.surg.2018.09.005. Epub 2018 Oct 25.

PMID:
30482518
7.

Ethnicity based variation in expression of E-cadherin in patients with squamous cell carcinoma of the oral tongue.

Sgaramella N, Wilms T, Boldrup L, Loljung L, Gu X, Coates PJ, Hassellöf P, Califano L, Lo Muzio L, Fåhraeus R, Norberg Spaak L, Franco R, Tartaro G, Colella G, Santagata M, Dell'Aversana Orabona G, Chirico F, Danielsson K, Troiano G, Ardito F, Nylander K.

Oncol Lett. 2018 Nov;16(5):6603-6607. doi: 10.3892/ol.2018.9452. Epub 2018 Sep 18.

8.

ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases.

Giuliante F, Ardito F.

Ann Surg. 2019 Jan;269(1):e15-e16. doi: 10.1097/SLA.0000000000003045. No abstract available.

PMID:
30247322
9.

Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma.

Ruzzenente A, Bagante F, Ardito F, Campagnaro T, Scoleri I, Conci S, Iacono C, Giuliante F, Guglielmi A.

Surgery. 2018 Aug;164(2):244-250. doi: 10.1016/j.surg.2018.03.012. Epub 2018 May 24.

PMID:
29801730
10.

Editorial: Head and Neck Cancer: Recent Findings and New Targets.

Ardito F, Muzio L, Soeiro Cordeiro MND, Concu R.

Curr Top Med Chem. 2018;18(3):173. doi: 10.2174/156802661803180514122453. No abstract available.

PMID:
29788865
11.

Effects of Curcumin on Squamous Cell Carcinoma of Tongue: An In Vitro Study.

Ardito F, Perrone D, Giuliani M, Testa NF, Muzio LL.

Curr Top Med Chem. 2018;18(3):233-243. doi: 10.2174/1568026618666180412153824.

PMID:
29651934
12.

In vitro evaluation of the cytotoxic activity of three epoxy resin-based endodontic sealers.

Troiano G, Perrone D, Dioguardi M, Buonavoglia A, Ardito F, Lo Muzio L.

Dent Mater J. 2018 Jun 8;37(3):374-378. doi: 10.4012/dmj.2017-148. Epub 2018 Mar 28.

13.

Genistein as a Potential Anticancer Agent Against Head and Neck Squamous Cell Carcinoma.

Ardito F, Di Gioia G, Pellegrino MR, Muzio LL.

Curr Top Med Chem. 2018;18(3):174-181. doi: 10.2174/1568026618666180116122650. Review.

PMID:
29345579
14.

Ultra-late recurrence of gastrointestinal stromal tumour: case report and literature review.

Grossi U, Ardito F, Petracca Ciavarella L, Goglia M, Giuliante F.

ANZ J Surg. 2019 May;89(5):E224-E225. doi: 10.1111/ans.14286. Epub 2017 Dec 1. No abstract available.

PMID:
29194890
15.

In vitro study on anti-cancer properties of genistein in tongue cancer.

Ardito F, Pellegrino MR, Perrone D, Troiano G, Cocco A, Lo Muzio L.

Onco Targets Ther. 2017 Nov 13;10:5405-5415. doi: 10.2147/OTT.S133632. eCollection 2017.

16.

Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.

Saviano A, Iezzi R, Giuliante F, Salvatore L, Mele C, Posa A, Ardito F, De Gaetano AM, Pompili M; HepatoCATT Study Group.

J Vasc Interv Radiol. 2017 Nov;28(11):1512-1519. doi: 10.1016/j.jvir.2017.06.016. Epub 2017 Jul 19.

PMID:
28734848
17.

Evaluation of chemical-physical properties and cytocompatibility of TheraCal LC.

Buonavoglia A, Lauritano D, Perrone D, Ardito F, Troiano G, Dioguardi M, Candotto V, Silvestre FJ, Lo Muzio L.

J Biol Regul Homeost Agents. 2017 Apr-Jun;31(2 Suppl 1):1-9.

PMID:
28691448
18.

Resveratrol (3,5,4'-trihydroxystilbene) and its properties in oral diseases.

Perrone D, Fuggetta MP, Ardito F, Cottarelli A, De Filippis A, Ravagnan G, De Maria S, Lo Muzio L.

Exp Ther Med. 2017 Jul;14(1):3-9. doi: 10.3892/etm.2017.4472. Epub 2017 May 18.

19.

The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review).

Ardito F, Giuliani M, Perrone D, Troiano G, Lo Muzio L.

Int J Mol Med. 2017 Aug;40(2):271-280. doi: 10.3892/ijmm.2017.3036. Epub 2017 Jun 22. Review.

20.

RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.

Brudvik KW, Jones RP, Giuliante F, Shindoh J, Passot G, Chung MH, Song J, Li L, Dagenborg VJ, Fretland ÅA, Røsok B, De Rose AM, Ardito F, Edwin B, Panettieri E, Larocca LM, Yamashita S, Conrad C, Aloia TA, Poston GJ, Bjørnbeth BA, Vauthey JN.

Ann Surg. 2019 Jan;269(1):120-126. doi: 10.1097/SLA.0000000000002319.

PMID:
28549012
21.

HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection.

Abbate V, Marcantoni M, Giuliante F, Vecchio FM, Gatto I, Mele C, Saviano A, Arciuolo D, Gaetani E, Ferrari MC, Giarretta I, Ardito F, Riccardi L, Nicoletti A, Ponziani FR, Gasbarrini A, Pompili M, Pola R.

Int J Mol Sci. 2017 May 12;18(5). pii: E1043. doi: 10.3390/ijms18051043.

22.

Patients with high c-MYC-expressing squamous cell carcinomas of the tongue show better survival than those with low- and medium-expressing tumours.

Strindlund K, Troiano G, Sgaramella N, Coates PJ, Gu X, Boldrup L, Califano L, Fahraeus R, Muzio LL, Ardito F, Colella G, Tartaro G, Franco R, Norberg-Spaak L, Saadat M, Nylander K.

J Oral Pathol Med. 2017 Nov;46(10):967-971. doi: 10.1111/jop.12579. Epub 2017 May 9.

PMID:
28393404
23.

Circulating miRNAs from blood, plasma or serum as promising clinical biomarkers in oral squamous cell carcinoma: A systematic review of current findings.

Troiano G, Boldrup L, Ardito F, Gu X, Lo Muzio L, Nylander K.

Oral Oncol. 2016 Dec;63:30-37. doi: 10.1016/j.oraloncology.2016.11.001. Epub 2016 Nov 10. Review.

PMID:
27938997
24.

Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis.

Giuliante F, Ardito F, Guglielmi A, Aldrighetti L, Ferrero A, Calise F, Giulini SM, Jovine E, Breccia C, De Rose AM, Pinna AD, Nuzzo G.

JAMA Surg. 2016 Oct 1;151(10):916-922. doi: 10.1001/jamasurg.2016.1769.

PMID:
27556741
25.

Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab.

Basso M, Dadduzio V, Ardito F, Lombardi P, Strippoli A, Vellone M, Orlandi A, Rossi S, Cerchiaro E, Cassano A, Giuliante F, Barone C.

Medicine (Baltimore). 2016 May;95(20):e3722. doi: 10.1097/MD.0000000000003722.

26.

Complications of Neck Dissections in Papillary Thyroid Carcinoma: A Modified Procedure to Reduce Parathyroid Morbidity.

Ardito G, Revelli L, Polistena A, Lucchini R, Giustozzi E, Guidi ML, Ardito F, Avenia N.

In Vivo. 2016 May-Jun;30(3):303-8.

PMID:
27107089
27.

Novel possibilities in the study of the salivary proteomic profile using SELDI-TOF/MS technology.

Ardito F, Perrone D, Cocchi R, Lo Russo L, DE Lillo A, Giannatempo G, Lo Muzio L.

Oncol Lett. 2016 Mar;11(3):1967-1972. Epub 2016 Feb 9.

28.

Anatomical liver resection of segment 4a en bloc with the caudate lobe.

Silvestrini N, Coppola A, Ardito F, Nuzzo G, Giuliante F.

J Surg Oncol. 2016 May;113(6):665-7. doi: 10.1002/jso.24202. Epub 2016 Feb 18.

PMID:
26891129
29.

Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study.

Autorino R, Mattiucci GC, Ardito F, Balducci M, Deodato F, Macchia G, Mantini G, Perri V, Tringali A, Gambacorta MA, Tagliaferri L, Giuliante F, Morganti AG, Valentini V.

Anticancer Res. 2016 Feb;36(2):737-40.

PMID:
26851032
30.

Biological and therapeutic activities, and anticancer properties of curcumin.

Perrone D, Ardito F, Giannatempo G, Dioguardi M, Troiano G, Lo Russo L, DE Lillo A, Laino L, Lo Muzio L.

Exp Ther Med. 2015 Nov;10(5):1615-1623. Epub 2015 Sep 17.

31.

Expression of salivary biomarkers in patients with oral mucositis: evaluation by SELDI-TOF/MS.

Ardito F, Giuliani M, Perrone D, Giannatempo G, Di Fede O, Favia G, Campisi G, Colella G, Lo Muzio L.

Oral Dis. 2016 Apr;22(3):209-19. doi: 10.1111/odi.12405. Epub 2016 Feb 19.

PMID:
26613366
32.

Clinical use of plasma chitotriosidase in severe sepsis.

Chiarla C, Giovannini I, Antuzzi D, Piras A, Ardito F, Giuliante F.

Curr Med Res Opin. 2016;32(2):273-6. doi: 10.1185/03007995.2015.1118370. Epub 2015 Dec 2.

PMID:
26550788
33.

The impact of intraoperative ultrasonography on the management of disappearing colorectal liver metastases.

Giuliante F, Panettieri E, Ardito F.

Hepat Oncol. 2015 Oct;2(4):325-328. doi: 10.2217/hep.15.29. Epub 2015 Nov 6. No abstract available.

34.

Liver Resection for Primary Intrahepatic Stones: Focus on Postoperative Infectious Complications.

Clemente G, De Rose AM, Murri R, Ardito F, Nuzzo G, Giuliante F.

World J Surg. 2016 Feb;40(2):433-9. doi: 10.1007/s00268-015-3227-x.

PMID:
26330236
35.

Cytotoxicity evaluation of five different dual-cured resin cements used for fiber posts cementation.

Dioguardi M, Perrone D, Troiano G, Laino L, Ardito F, Lauritano F, Cicciù M, Muzio LL.

Int J Clin Exp Med. 2015 Mar 7;8(6):9327-33. eCollection 2015.

36.

Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features.

Ciresa M, De Gaetano AM, Pompili M, Saviano A, Infante A, Montagna M, Guerra A, Giuga M, Vellone M, Ardito F, De Rose A, Giuliante F, Vecchio FM, Gasbarrini A, Bonomo L.

Eur Rev Med Pharmacol Sci. 2015 Aug;19(15):2786-97.

37.

Primary hepatic angiosarcoma.

Coppola A, Bianco G, Ardito F, Giovannini I, Giuliante F.

ANZ J Surg. 2018 Jan;88(1-2):E75-E76. doi: 10.1111/ans.13244. Epub 2015 Jul 28. No abstract available.

PMID:
26216782
38.

Minimally invasive liver surgery in a hepato-biliary unit: learning curve and indications.

Giuliante F, Ardito F.

Updates Surg. 2015 Jun;67(2):201-6. doi: 10.1007/s13304-015-0314-3. Epub 2015 Jul 21.

PMID:
26194991
39.

Strong YB-1 expression predicts liver recurrence following resection for colorectal metastases.

Ardito F, Arena V, Vellone M, Grande G, Pennacchia I, Majellaro F, Giovannini I, Vecchio FM, Nuzzo G, Giuliante F.

J Gastrointest Surg. 2014 Nov;18(11):1987-93. doi: 10.1007/s11605-014-2657-3. Epub 2014 Sep 18.

PMID:
25231080
40.

Impairment of hepatocellular excretory function, sepsis and liver insufficiency after liver resection.

Chiarla C, Giovannini I, Ardito F, Vellone M, Nuzzo G, Giuliante F.

Crit Care. 2014 Mar 25;18(2):419. doi: 10.1186/cc13792. No abstract available.

41.

Tumor progression during preoperative chemotherapy predicts failure to complete 2-stage hepatectomy for colorectal liver metastases: results of an Italian multicenter analysis of 130 patients.

Giuliante F, Ardito F, Ferrero A, Aldrighetti L, Ercolani G, Grande G, Ratti F, Giovannini I, Federico B, Pinna AD, Capussotti L, Nuzzo G.

J Am Coll Surg. 2014 Aug;219(2):285-94. doi: 10.1016/j.jamcollsurg.2014.01.063. Epub 2014 Apr 13.

PMID:
24933714
42.

Papillary thyroid microcarcinoma: proposal of treatment based on histological prognostic factors evaluation.

Ardito G, Avenia N, Giustozzi E, Salvatori M, Fadda G, Ardito F, Revelli L.

Ann Ital Chir. 2014 Jan-Feb;85(1):1-5.

PMID:
24755735
43.

Intraoperative liver ultrasound still affects surgical strategy for patients with colorectal metastases in the modern era.

Ferrero A, Langella S, Giuliante F, Viganò L, Vellone M, Zimmitti G, Ardito F, Nuzzo G, Capussotti L.

World J Surg. 2013 Nov;37(11):2655-63. doi: 10.1007/s00268-013-2183-6.

PMID:
23974959
44.

Long-term outcome after laparoscopic fenestration of simple liver cysts.

Ardito F, Bianco G, Vellone M, Sarno G, Ranucci G, Giovannini I, Giuliante F.

Surg Endosc. 2013 Dec;27(12):4670-4. doi: 10.1007/s00464-013-3104-3. Epub 2013 Aug 13.

PMID:
23943117
45.

Clinical characteristics and survival of European patients with resectable large hepatocellular carcinomas.

Giuliante F, De Rose AM, Guerra V, Ardito F, Nuzzo G, Carr BI.

J Gastrointest Cancer. 2013 Sep;44(3):329-35. doi: 10.1007/s12029-013-9523-5.

PMID:
23912605
46.

Liver resection for hepatocellular carcinoma in patient with situs inversus viscerum.

Ranucci G, Ardito F, Silvestrini N, Grieco A, Giuliante F.

Updates Surg. 2014 Mar;66(1):91-2. doi: 10.1007/s13304-013-0221-4. Epub 2013 Jun 22. No abstract available.

PMID:
23794154
47.

Right and extended-right hepatectomies for unilobar colorectal metastases: impact of portal vein embolization on long-term outcome and liver recurrence.

Ardito F, Vellone M, Barbaro B, Grande G, Clemente G, Giovannini I, Federico B, Bonomo L, Nuzzo G, Giuliante F.

Surgery. 2013 Jun;153(6):801-10. doi: 10.1016/j.surg.2013.02.001.

PMID:
23701876
48.

Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey.

Pompili M, Saviano A, de Matthaeis N, Cucchetti A, Ardito F, Federico B, Brunello F, Pinna AD, Giorgio A, Giulini SM, De Sio I, Torzilli G, Fornari F, Capussotti L, Guglielmi A, Piscaglia F, Aldrighetti L, Caturelli E, Calise F, Nuzzo G, Rapaccini GL, Giuliante F.

J Hepatol. 2013 Jul;59(1):89-97. doi: 10.1016/j.jhep.2013.03.009. Epub 2013 Mar 22.

PMID:
23523578
49.

Prognostic significance of tumor doubling time in mass-forming type cholangiocarcinoma.

De Rose AM, Cucchetti A, Clemente G, Ardito F, Giovannini I, Ercolani G, Giuliante F, Pinna AD, Nuzzo G.

J Gastrointest Surg. 2013 Apr;17(4):739-47. doi: 10.1007/s11605-012-2129-6. Epub 2013 Jan 5.

PMID:
23292461
50.

Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy.

Ardito G, Revelli L, Giustozzi E, Salvatori M, Fadda G, Ardito F, Avenia N, Ferretti A, Rampin L, Chondrogiannis S, Colletti PM, Rubello D.

Clin Nucl Med. 2013 Jan;38(1):25-8. doi: 10.1097/RLU.0b013e318279bc65.

PMID:
23242040

Supplemental Content

Loading ...
Support Center